Banque Pictet & Cie Sa Viatris Inc Transaction History

Banque Pictet & Cie Sa

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$9.2 - $12.26 $1.01 Million - $1.35 Million	110,220 Added 98.93%	221,637 $2.13 Million
Q4 2022 Feb 06, 2023	BUY	$8.72 - $11.56 $350,125 - $464,157	40,152 Added 56.34%	111,417 $0
Q3 2022 Nov 10, 2022	SELL	$8.48 - $11.13 $729,704 - $957,736	-86,050 Reduced 54.7%	71,265 $607 Million
Q2 2022 Aug 08, 2022	SELL	$9.95 - $12.27 $427,133 - $526,726	-42,928 Reduced 21.44%	157,315 $1.65 Million
Q1 2022 May 04, 2022	SELL	$9.81 - $15.4 $253,912 - $398,598	-25,883 Reduced 11.45%	200,243 $2.18 Million
Q4 2021 Feb 02, 2022	BUY	$12.09 - $14.68 $2.73 Million - $3.32 Million	226,126 New	226,126 $3.06 Million
Q2 2021 Aug 12, 2021	SELL	$12.97 - $16.15 $1.2 Million - $1.49 Million	-92,157 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$13.59 - $18.54 $64,797 - $88,398	-4,768 Reduced 4.92%	92,157 $1.29 Million
Q4 2020 Feb 10, 2021	BUY	$14.3 - $18.74 $1.39 Million - $1.82 Million	96,925 New	96,925 $1.82 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

Stay updated on Banque Pictet & Cie Sa with notifications on news.